Literature DB >> 10202800

Inflammatory bowel disease. Current perspectives.

A E Jergens1.   

Abstract

This review provides current perspectives on canine and feline (IBD) as documented in the literature. As can be seen, the scientific database on this clinical syndrome is minute. Empirical clinical observations and experiences are valuable but do not replace the "good science" that can be achieved by performance of basic science research studies and controlled therapeutic trials. Continued advances in immunobiology, particularly molecular biology, should facilitate a greater understanding of IBD in both humans and animals. Indeed, preliminary investigations using these research tools have provided new insights into the immunopathology of canine IBD.

Entities:  

Mesh:

Year:  1999        PMID: 10202800

Source DB:  PubMed          Journal:  Vet Clin North Am Small Anim Pract        ISSN: 0195-5616            Impact factor:   2.093


  17 in total

1.  Evaluation of silymarin in the treatment on asymptomatic Giardia infections in dogs.

Authors:  Seung-Ki Chon; Nam-Soo Kim
Journal:  Parasitol Res       Date:  2005-09-09       Impact factor: 2.289

2.  Serum gastrin in canine chronic lymphocytic-plasmacytic enteritis.

Authors:  Mercedes García-Sancho; Fernando Rodríguez-Franco; Angel Sainz; Antonio Rodríguez; Gema Silván; Juan Carlos Illera
Journal:  Can Vet J       Date:  2005-07       Impact factor: 1.008

3.  Severe lymphocytic-plasmacytic and atrophic gastritis, as well as, predominantly eosinophilic, severe enteritis, in a 19-month-old Labrador retriever.

Authors:  Marjolaine Rousseau
Journal:  Can Vet J       Date:  2005-03       Impact factor: 1.008

4.  Chronic Enteropathy in Dogs-Epidemiologic Aspects and Clinical Characteristics of Dogs Presenting at Two Swedish Animal Hospitals.

Authors:  Johanna Holmberg; Lena Pelander; Ingrid Ljungvall; Caroline Harlos; Thomas Spillmann; Jens Häggström
Journal:  Animals (Basel)       Date:  2022-06-09       Impact factor: 3.231

5.  Intestinal cytokine mRNA expression in canine inflammatory bowel disease: a meta-analysis with critical appraisal.

Authors:  Albert E Jergens; Ioana M Sonea; Annette M O'Connor; Linda K Kauffman; Sinisa D Grozdanic; Mark R Ackermann; Richard B Evans
Journal:  Comp Med       Date:  2009-04       Impact factor: 0.982

6.  Eosinophilic gastroenteritis in a dog.

Authors:  Sarah McTavish
Journal:  Can Vet J       Date:  2002-06       Impact factor: 1.008

7.  A case of non-regenerative immune-mediated anemia treated by combination therapy of human immune globulin and mycophenolate mofetil in a dog.

Authors:  M Yuki
Journal:  Open Vet J       Date:  2011-12-03

8.  Rifaximin is an effective alternative to metronidazole for the treatment of chronic enteropathy in dogs: a randomised trial.

Authors:  Alessandro Menozzi; Manuel Dall'Aglio; Fausto Quintavalla; Luca Dallavalle; Valentina Meucci; Simone Bertini
Journal:  BMC Vet Res       Date:  2016-10-06       Impact factor: 2.741

9.  Feed-forward inhibition of CD73 and upregulation of adenosine deaminase contribute to the loss of adenosine neuromodulation in postinflammatory ileitis.

Authors:  Cátia Vieira; Maria Teresa Magalhães-Cardoso; Fátima Ferreirinha; Isabel Silva; Ana Sofia Dias; Julie Pelletier; Jean Sévigny; Paulo Correia-de-Sá
Journal:  Mediators Inflamm       Date:  2014-08-19       Impact factor: 4.711

10.  Immunohistochemical expression of ornithine decarboxylase, diamine oxidase, putrescine, and spermine in normal canine enterocolic mucosa, in chronic colitis, and in colorectal cancer.

Authors:  Giacomo Rossi; Matteo Cerquetella; Graziano Pengo; Subeide Mari; Emilia Balint; Gabrio Bassotti; Nicolae Manolescu
Journal:  Biomed Res Int       Date:  2015-10-15       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.